Three Year Data on the Performance of Three Renal Artery Bridging Stent Grafts in Branched Endovascular Repair of Thoraco-Abdominal Pathologies
European Journal of Vascular and Endovascular Surgery · 2025-09 · 70 (3) · 318-325
DOI: 10.1016/j.ejvs.2025.02.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2025-09. Verfasst von Rebecca Kolet und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Vascular Surgery and Phlebology, St Franziskus Hospital, Münster, Germany. Hauptthemen laut MEDLINE: Renal Artery, Endovascular Procedures, Blood Vessel Prosthesis, Stents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Previous studies have shown that branched endovascular aneurysm repair (B-EVAR) carries a significant risk of adverse renal events. The purpose of this study was to evaluate the performance of the balloon expandable covered stentgraft (BECS) Advanta/iCast V12, the Viabahn balloon expandable stent (VBX), and the BECS Advanta stent combined with a distally deployed self expanding covered stentgraft (SECS) Viabahn (VSX) as bridging stent grafts (BSGs) in renal arteries. METHODS: A retrospective analysis of prospectively collected data was conducted at a single centre. Patients undergoing B-EVAR who had at least one Advanta, Advanta + VSX, or VBX as renal artery BSGs were included. Endpoints were patency, endoleaks, target vessel instability (TVI), re-interventions, as well as clinical outcomes including kidney function, new dialysis needs, and death. Data were analysed using Kaplan-Meier estimates and multivariable Cox regression. RESULTS: The study included 255 patients with 431 renal artery BSGs treated by complex aortic repair between 2010 and 2019. Advanta was used predominantly in 2010 - 2014, Advanta + VSX in 2015 - 2017, and VBX in 2018 - 2019. Overall, 125 Advanta, 146 Advanta + VSX, and 160 VBX stents were implanted. The median follow up was 19.3 months. At three years, estimated primary patencies were 82.7 ± 4.6% for renal arteries treated with Advanta, 96.8 ± 1.8% for Advanta + VSX, and 89.0 ± 3.2% for VBX. Estimated freedom from TVI at three years was 82.4 ± 4.7% for renal arteries treated with Advanta, 94.1 ± 2.4% for Advanta + VSX, and 85.4 ± 3.5% for VBX. Freedom from re-intervention estimations at three years were 86.3 ± 3.4% in the Advanta cohort, 95.1 ± 2.0% in the Advanta + VSX cohort, and 91.6 ± 2.4% in the VBX cohort. CONCLUSION: The combination of BECS and SECS seems to be superior in terms of primary patency compared with BECS alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic for Vascular Surgery and Phlebology, St Franziskus Hospital, Münster, Germany.
- Institut für Biometrie und klinische Forschung, University of Münster, Münster, Germany.
- Clinic for Vascular Surgery and Phlebology, St Franziskus Hospital, Münster, Germany. Electronic address: martin.austermann@sfh-muenster.de.
Zitieren
APA
Kolet, R., Usai, M. V., Shehada, Y., Berekhoven, B., Weyer-Elberich, V., & Austermann, M. (2025). Three Year Data on the Performance of Three Renal Artery Bridging Stent Grafts in Branched Endovascular Repair of Thoraco-Abdominal Pathologies. European Journal of Vascular and Endovascular Surgery, 70(3), 318-325. https://doi.org/10.1016/j.ejvs.2025.02.034
Vancouver
Kolet R, Usai MV, Shehada Y, Berekhoven B, Weyer-Elberich V, Austermann M. Three Year Data on the Performance of Three Renal Artery Bridging Stent Grafts in Branched Endovascular Repair of Thoraco-Abdominal Pathologies. European Journal of Vascular and Endovascular Surgery. 2025;70(3):318-325. doi:10.1016/j.ejvs.2025.02.034
BibTeX
@article{Kolet2025,
author = {Kolet, Rebecca and Usai, Marco Virgilio and Shehada, Yousef and Berekhoven, Bärbel and Weyer-Elberich, Veronika and Austermann, Martin},
title = {Three Year Data on the Performance of Three Renal Artery Bridging Stent Grafts in Branched Endovascular Repair of Thoraco-Abdominal Pathologies},
journal = {European Journal of Vascular and Endovascular Surgery},
year = {2025},
volume = {70},
number = {3},
pages = {318--325},
doi = {10.1016/j.ejvs.2025.02.034}
}
EUVIMED